News & Updates | Ling Laboratory

The Texas Biomed Journal Club

April 15th, 2024

The Ling Lab's graduate student Whitney Ortiz presented at Texas Biomed's monthly Journal Club session on behalf of the Host-Pathogen Interactions Program.

JournalClub-PNG

28th Scientific Conference

March 10-13, 2024 SNIP

Dr. Binhua (Julie) Ling attended the 28th Scientific Conference of the Society on NeuroImmune Pharmacology (SNIP) in Charleston, SC, as an invited speaker.

Visit the official website for event details.

Congratulations Inventors

February 6 2024

An external file that holds a picture, illustration, etc. Object name is bbac111f5.jpg Binhua “Julie” Ling, MD, PhD, and Fei Wu, a visiting PhD student
Title of Invention (Computer Program): Meta-Transcriptome Detector (MTD) – a unique pipeline for host and meta-transcriptome joint and integrative analyses of RNA-seq data.

Promotion

January 1, 2024

Congratulations

Ling Lab's Grey De La Torre, M.Sc., was promoted from Senior Research Assistant to Research Associate!

Latest Publication on Science Translational Medicine

December 13, 2023

ScienceTM Dr. Ling's lab and collaborators publish research article "Lymphoid tissues contribute to plasma viral clonotypes early after antiretroviral therapy interruption in SIV-infected rhesus macaques" on Science Translational Medicine, and was featured on the cover page of the journal's online issue.

See: Science Translational Medicine | AAAS.

2023 Annual Vaccine Development Center of San Antonio Conference

November 9, 2023 Vaccineconference

Ling Lab's doctoral student Whitney Ortiz was selected to participate in the poster session of the 11th annual Vaccine Development Center of San Antonio (VDCoSA) conference.

Visit the official website to learn more about the event's program.

The Texas Biomed Journal Club

October 16, 2023

Boby's Journal Club The Ling Lab's postdoctoral scientist Nongthombam Boby, DVM, Ph.D. presented at Texas Biomed's monthly Journal Club session on behalf of the Host-Pathogen Interactions Program.

Promotion

September 26, 2023 Congratulations

Ling Lab's Dr. Nongthombam Boby, DVM, Ph.D., was promoted from Postdoctoral Scientist 4 to Postdoctoral Scientist 5!

Antonio Solis-Leal, Ph.D. awarded 1st Place in category at Texas Biomed Research Symposium.

September 14th and 15th, 2023

Ling Lab's postdoctoral scientist, Antonio Solis-Leal, Ph.D., participated at Texas Biomedical Research Institute's annual Research Symposium and was awarded first place for "Exemplary Short Talk" by a Postdoctoral Scientist.

Promotion

August 21, 2023 Congratulations

Dr. Binhua (Julie) Ling, M.D., Ph.D. was promoted to Program Lead for the Host-Pathogen Interactions program!

Beyond the blood-brain barrier: HIV research at Texas Biomed gets NIH funding boost

July 27, 2022

The $3.9 million grant supports research exploring how gene-editing technology may help eradicate HIV in the brain.

Finding a cure for HIV has been extremely difficult, in part because the virus hides from antiretroviral treatments in one of the hardest places to reach: the brain.

Texas Biomed Associate Professor Binhua “Julie” Ling, MD, PhD, and Temple University Professor Wenhui Hu, MD, PhD, will study whether they can find and eliminate the virus from infected brain cells using the latest gene-editing technology, CRISPR, combined with old-school virology.

View Full Article.

New Tool Integrates Microbiome and Host Genetic Sequencing Analysis

May 5, 2022

MTD Researchers at Texas Biomedical Research Institute and Tulane University have developed a new software tool that makes it easier, faster and more cost effective to analyze genetic information about a host and its microbiome at the same time. The software, called “meta-transcriptome detector” (MTD), can be used by a wide range of microbiologists and drug developers, including those researching diseases such as certain cancers, COVID-19, HIV/AIDS, malaria and many other human health conditions linked to microorganisms.

The tool was recently published in the journal Briefings in Bioinformatics.

See Full Article